SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-18-000032
Filing Date
2018-05-10
Accepted
2018-05-10 16:15:54
Documents
4
Period of Report
2018-05-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a90879878-creditagreementl.htm 8-K 33583
2 EXHIBIT 99.1 a20180510-991.htm EX-99.1 12798
3 g274847img1a03.jpg GRAPHIC 17603
4 valeantlogofooter2.gif GRAPHIC 8312
  Complete submission text file 0000885590-18-000032.txt   83639
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 18822707
SIC: 2834 Pharmaceutical Preparations